Case Study: Leading Women’s Healthcare Company achieves on-time, compliant commercial launch and full channel visibility with IntegriChain

Delivering the Commercialization Platform for Success in Women’s Health

Leading Women’s Healthcare Company, an emerging pharmaceutical manufacturer preparing a Q4 2020 launch for a new women’s health therapy after multiple FDA CRLs, faced payer coverage risk (Medicaid/Medicare), limited downstream inventory visibility, unpredictable gross-to-net (GTN) accruals and forecasting, immediate compliance needs, and little bandwidth to manage multiple vendors. They engaged IntegriChain and its commercialization platform, including Channel Data Aggregation, Inventory Analytics, Government Pricing and Rebate Managed Services, and GTN solutions to address these gaps.

IntegriChain aggregated channel data and provided 100% downstream inventory visibility, implemented GP and rebate managed services to ensure compliance, and delivered audit-ready GTN forecasts and accruals that improved forecast accuracy and reduced stock-out and accrual risks. As a result, the Leading Women’s Healthcare Company met its launch readiness goals, achieved consistent, auditable pricing and forecasting processes, and gained confidence that its commercialization platform can support current and future growth.